BiotechTube
OnsiteGene

OnsiteGene

San Diego, United States· Est.
onsitegene.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.2M

Overview

OnsiteGene is a private, commercial-stage diagnostics and life science tools company founded in 2019 and headquartered in San Diego, CA. It has developed a proprietary ultra-fast PCR platform, highlighted by its flagship XDive 5-minute qPCR instrument, which is validated through inclusion in the NIH RADx program. The company is expanding its portfolio with a cartridge-based, sample-to-answer system (PeakV) and offers OEM and assay development services, positioning itself at the intersection of rapid molecular testing for research, industrial, and clinical point-of-care markets.

Infectious DiseaseOncology

Technology Platform

Proprietary ultra-fast real-time PCR technology enabling 40-cycle qPCR in 5 minutes, integrated with automated, cartridge-based sample-to-answer systems for ultra-sensitive nucleic acid testing.

Funding History

1
Total raised:$1.2M
Seed$1.2M

Opportunities

The growing demand for rapid, point-of-care molecular diagnostics presents a massive opportunity, especially for infectious disease testing and liquid biopsy.
Expansion of its assay menu and securing regulatory clearances for clinical use of its PeakV system could drive significant market penetration.

Risk Factors

Key risks include intense competition from established diagnostic companies, execution challenges in developing and manufacturing a complex, integrated cartridge system, and the need to secure substantial regulatory approvals and commercial partnerships to succeed in the clinical market.

Competitive Landscape

OnsiteGene competes in the fast-growing rapid molecular diagnostics space against large, established players like Abbott (ID NOW), Cepheid (GeneXpert), and BioFire (FilmArray), as well as other startups. Its differentiation is the extreme speed (5-minute PCR) of its core technology and its pursuit of ultra-sensitivity for applications like liquid biopsy.

More companies in Diagnostics & Precision Medicine →More companies in United States →